Guinea pig Pancreatic lipase-related protein 2 (PNLIPRP2) ELISA Kit
| Product Name | Guinea pig Pancreatic lipase-related protein 2 (PNLIPRP2) ELISA Kit |
|---|---|
| Description | PNLIPRP2 has 65% amino acid sequence identity with PNLIP, 63% identity with PNLIPRP1, and 20 to 30% identity with human gastric lipase, lipoprotein lipase, and hepatic lipase. Western blot analysis of recombinant PNLIPRP2 expressed in mammalian cells detected a secreted, approximately 50-kD protein; the authors concluded that PNLIPRP2 was glycosylated. In a standard pancreatic lipase assay, recombinant PNLIPRP2 showed lipolytic activity that was marginally increased by the addition of colipase and was inhibited by the lipase inhibitor orlistat. Northern blot analysis of pancreas RNA detected major 2.3- and 1.8-kb PNLIPRP2 transcripts. The expression level of PNLIPRP2 in pancreas was approximately 24-fold lower and 6-fold lower than the expression levels of PNLIP and PNLIPRP1, respectively. This assay has high sensitivity and excellent specificity for detection of Guinea pig PNLIPRP2. No significant cross-reactivity or interference between Guinea pig PNLIPRP2 and analogues was observed. |
| Synonyms | PLRP2, |
| Method | Sandwich ELISA |
| Detection Range | Request Information |
| Sensitivity | Request Information |
| Reactivity | Guinea Pig |
| Sample Types | Serum, Plasma, Other biological fluids. |
| Background | PNLIPRP2 has 65% amino acid sequence identity with PNLIP, 63% identity with PNLIPRP1, and 20 to 30% identity with human gastric lipase, lipoprotein lipase, and hepatic lipase. Western blot analysis of recombinant PNLIPRP2 expressed in mammalian cells detected a secreted, approximately 50-kD protein; the authors concluded that PNLIPRP2 was glycosylated. In a standard pancreatic lipase assay, recombinant PNLIPRP2 showed lipolytic activity that was marginally increased by the addition of colipase and was inhibited by the lipase inhibitor orlistat. Northern blot analysis of pancreas RNA detected major 2.3- and 1.8-kb PNLIPRP2 transcripts. The expression level of PNLIPRP2 in pancreas was approximately 24-fold lower and 6-fold lower than the expression levels of PNLIP and PNLIPRP1, respectively. |
| Supplier | Abebio |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
